Vital unlicensed and off-label drug use thwarts paediatric rights

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.374, 2002-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Off-label and unlicensed use of antidotes in paediatric patients

By Lifshitz Matityahu Gavrilov Vladimir Gorodischer Rafael

European Journal of Clinical Pharmacology, Vol. 56, Iss. 11, 2001-01 ,pp. : 839-841

Springer Publishing Company

Access to resources Recommend Favorite

Unlicensed and Off-Label Drug Use: Issues and Recommendations

By Conroy S.

Pediatric Drugs, Vol. 4, Iss. 6, 2002-01 ,pp. : 353-359

Adis International

Access to resources Recommend Favorite

The Impact of Unlicensed and Off-Label Drug Use on Adverse Drug Reactions in Paediatric Patients

By Antje Neubert

Drug Safety, Vol. 27, Iss. 13, 2004-01 ,pp. : 1059-1067

Adis International

Access to resources Recommend Favorite

Unlicensed and off-label drug use in children: implications for safety

By Choonara Imti

Expert Opinion on Drug Safety, Vol. 3, Iss. 2, 2004-03 ,pp. : 81-83

Informa Healthcare

Access to resources Recommend Favorite

Unlicensed and Off-Label Drug Use in Children: Implications for Safety

By Choonara I. Conroy S.

Drug Safety, Vol. 25, Iss. 1, 2002-01 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite